ICON PLC
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical stu… Read more
Market Cap & Net Worth: ICON PLC (ICLR)
ICON PLC (NASDAQ:ICLR) has a market capitalization of $7.67 Billion ($7.67 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #2130 globally and #1532 in its home market, demonstrating a -8.67% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying ICON PLC's stock price $100.49 by its total outstanding shares 76359932 (76.36 Million).
ICON PLC Market Cap History: 2015 to 2026
ICON PLC's market capitalization history from 2015 to 2026. Data shows growth from $5.93 Billion to $7.67 Billion (3.13% CAGR).
Index Memberships
ICON PLC is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.32% | #47 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.02% | #272 of 3165 |
Weight: ICON PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
ICON PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how ICON PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.93x
ICON PLC's market cap is 1.93 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
20.23x
ICON PLC's market cap is 20.23 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $5.93 Billion | $1.57 Billion | $239.54 Million | 3.77x | 24.77x |
| 2016 | $5.74 Billion | $1.67 Billion | $262.18 Million | 3.45x | 21.90x |
| 2017 | $8.56 Billion | $1.76 Billion | $281.49 Million | 4.87x | 30.42x |
| 2018 | $9.87 Billion | $2.60 Billion | $322.82 Million | 3.80x | 30.56x |
| 2019 | $13.15 Billion | $2.81 Billion | $373.99 Million | 4.69x | 35.17x |
| 2020 | $14.89 Billion | $2.80 Billion | $327.81 Million | 5.32x | 45.42x |
| 2021 | $23.65 Billion | $5.48 Billion | $153.19 Million | 4.31x | 154.38x |
| 2022 | $14.83 Billion | $7.74 Billion | $505.30 Million | 1.92x | 29.35x |
| 2023 | $21.62 Billion | $8.12 Billion | $612.34 Million | 2.66x | 35.30x |
| 2024 | $16.01 Billion | $8.28 Billion | $791.47 Million | 1.93x | 20.23x |
Competitor Companies of ICLR by Market Capitalization
Companies near ICON PLC in the global market cap rankings as of March 18, 2026.
Key companies related to ICON PLC by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
ICON PLC Historical Marketcap From 2015 to 2026
Between 2015 and today, ICON PLC's market cap moved from $5.93 Billion to $ 7.67 Billion, with a yearly change of 3.13%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $7.67 Billion | -44.85% |
| 2025 | $13.91 Billion | -13.11% |
| 2024 | $16.01 Billion | -25.92% |
| 2023 | $21.62 Billion | +45.72% |
| 2022 | $14.83 Billion | -37.28% |
| 2021 | $23.65 Billion | +58.84% |
| 2020 | $14.89 Billion | +13.21% |
| 2019 | $13.15 Billion | +33.29% |
| 2018 | $9.87 Billion | +15.21% |
| 2017 | $8.56 Billion | +49.14% |
| 2016 | $5.74 Billion | -3.22% |
| 2015 | $5.93 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of ICON PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.67 Billion USD |
| MoneyControl | $7.67 Billion USD |
| MarketWatch | $7.67 Billion USD |
| marketcap.company | $7.67 Billion USD |
| Reuters | $7.67 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.